Hepatitis C virus genotypes and clinical features in hepatitis C virus-related mixed cryoglobulinemia. 1998

L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
Terza Divisione di Medicina Interna, IRCCS Ospedale Maggiore, Milan, Italy.

Mixed cryoglobulinemia is a systemic disease, almost always associated with hepatitis C virus infection and characterized by purpura and cutaneous vasculitis, asthenia, arthralgias, and often renal and neurological involvement. No significant differences have been described to date in mixed cryoglobulinemia patients with type 1, 2, or 3 hepatitis C virus infection with respect to symptoms, while a higher prevalence of genotype 2a has been reported in patients without clinical and biochemical signs of liver disease or with serum autoantibodies. We examined 33 hepatitis C virus-positive patients with mixed cryoglobulinemia to assess if any clinical or serological feature is related to infection with different genotypes. All subjects underwent viral genotype determination by means of a single-step polymerase chain reaction. Thirteen patients (39%) were infected with hepatitis C virus type 1b, 17 (52%) with type 2a or 2a/c, and 3 (9%) with type 3. There was a significant difference in the frequency of peripheral nervous system involvement: paresthesias or other symptoms of peripheral neuropathy were less frequent in patients with 2a or 2a/c infection (29%) than in patients with type 1b or type 3 infection (88%, P = 0.003). Only patients with hepatitis C virus type 2 had urticaria or cutaneous ulcers. These patients also had a lower frequency of arthralgias, lower cryocrit values (P = 0.02), and lower serum levels of alanine-aminotransferase and gamma-glutamyl-transpeptidase (P < 0.04) than patients with type 1 and type 3 infection. The prevalence of antinuclear antibody positivity was similar in the three groups.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
January 1998, Journal of medical virology,
L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
May 2010, The American journal of medicine,
L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
February 1994, The American journal of medicine,
L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
November 1993, Medicina clinica,
L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
January 1991, Clinical and experimental rheumatology,
L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
March 1995, Hospital practice (Office ed.),
L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
May 2017, Pharmacogenomics,
L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
July 2013, Hepatology (Baltimore, Md.),
L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
March 2007, Minerva gastroenterologica e dietologica,
L Origgi, and M Vanoli, and G Lunghi, and A Carbone, and M Grasso, and R Scorza
September 1992, The American journal of gastroenterology,
Copied contents to your clipboard!